Recent RCKT News
- Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress • Business Wire • 02/26/2026 09:00:00 PM
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 02/23/2026 12:00:00 PM
- Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference • Business Wire • 01/05/2026 12:00:00 PM
- Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions • PR Newswire (US) • 12/09/2025 04:57:00 PM
- Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions • PR Newswire (Canada) • 12/09/2025 04:57:00 PM
- Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference • Business Wire • 11/25/2025 12:00:00 PM
- Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress • Business Wire • 11/06/2025 09:00:00 PM
- Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) • Business Wire • 10/14/2025 11:00:00 AM
- Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/10/2025 08:00:00 PM
- Kuehn Law Encourages Investors of Rocket Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 09/19/2025 05:30:00 PM
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 08/28/2025 11:00:00 AM
- Rocket Pharmaceuticals surges as FDA lifts clinical hold on Phase 2 trial • IH Market News • 08/20/2025 12:56:27 PM
- Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease • Business Wire • 08/20/2025 11:00:00 AM
- Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 08/11/2025 12:45:00 PM
- Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress • Business Wire • 08/07/2025 08:00:00 PM
- Lost Money on Rocket Pharmaceuticals, Inc.(RCKT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 08/07/2025 12:45:00 PM
- Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RCKT • PR Newswire (US) • 08/04/2025 12:45:00 PM
- Investors in Rocket Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT • PR Newswire (US) • 07/31/2025 12:45:00 PM
- Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before August 11, 2025 to Discuss Your Rights - RCKT • PR Newswire (US) • 07/28/2025 12:45:00 PM
- The Gross Law Firm Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 07/24/2025 12:45:00 PM
- Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs • Business Wire • 07/24/2025 11:00:00 AM
- Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) - August 11, 2025 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 07/21/2025 12:45:00 PM
- Rocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene Therapy • IH Market News • 07/17/2025 02:24:12 PM
- Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - RCKT • PR Newswire (US) • 07/17/2025 01:00:00 PM
- Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy • Business Wire • 07/17/2025 11:00:00 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
